Not applicableStudy completedNCT05096091
What this trial is testing
International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)
Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 5,399